Abeona Therapeutics, Inc.
(NASDAQ : ABEO)

( )
ABEO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.03%186.071.9%$326.91m
TEVATeva Pharmaceutical Industries Ltd. -0.10%10.182.0%$75.04m
JAGXJaguar Health, Inc. -1.19%1.660.9%$28.69m
KINKindred Biosciences, Inc. 0.00%9.210.2%$25.38m
RDYDr. Reddy's Laboratories Ltd. -0.10%71.332.0%$7.44m
TXMDTherapeuticsMD, Inc. 0.00%1.2015.3%$5.75m
COCPCocrystal Pharma, Inc. -0.75%1.330.0%$5.02m
ABEOAbeona Therapeutics, Inc. 1.24%1.643.7%$2.12m
TAROTaro Pharmaceutical Industries Ltd. -0.01%71.766.6%$1.98m
CPHIChina Pharma Holdings, Inc. -0.14%0.710.1%$1.18m
LFVNLifeVantage Corp. 0.00%6.903.4%$0.54m

Company Profile

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.